Overview
Drug card for a generic or brand name: RxNorm concept (RxCUI, ingredients, brands); one openFDA label (brand checked against RxNorm ingredients, else single-ingredient full prescribing info, most common route, earliest NDA/BLA) with clipped boxed warning, indications, dosing, contraindications, warnings, interactions, pregnancy, lactation, special-formulation flag, other routes, DailyMed link; DEA schedule and status (NDC data); FDA shortage and 2-year recall summaries.
Protocol
x402
Price
$0.02
Payment Asset
USD Coin
Payment Network
eip155:8453
Category
uncategorized
Provider
Kit Rx
Source
self-registered
Indexed
2026-11-13 21:58:53
Health
Status
healthy
Latency (p50)
—
Uptime (30d)
—
Reliability Score
—
Last Checked
Never
Last Healthy
Never
Consecutive Failures
0
Output Schema
{
"example": {
"attribution": [
"This product uses …"
],
"generated_at": "2026-11-13T21:50:07.688Z",
"notes": [
"Informational summary of …"
],
"query": {
"name": "Vyvanse"
},
"result": {
"dea_schedule": "CII",
"dea_schedule_status": "controlled",
"label": {
"application_number": "NDA021977",
"brand_name": "Vyvanse",
"generic_name": "LISDEXAMFETAMINE DIMESYLATE",
"manufacturer": "Takeda Pharmaceuticals …",
"other_routes": [],
"pharm_class_epc": [],
"pharm_class_moa": [],
"product_type": "HUMAN PRESCRIPTION DRUG",
"route": [
"ORAL"
],
"special_formulation": null
},
"recalls": {
"count": 9,
"from": "2024-11-13",
"match_basis": "product description …",
"months": 24,
"most_recent": [
{}
],
"to": "2026-11-13"
},
"rxnorm": {
"brand_names": [
"Vyvanse"
],
"ingredients": [
{}
],
"name": "Vyvanse",
"rxcui": "711043",
"tty": "BN"
},
"shortages": {
"counts_by_status": {
"current": 90,
"resolved": 0,
"to_be_discontinued": 0
},
"current": [
{}
],
"in_shortage": true,
"match_basis": "shortage generic name …",
"products": [
"Lisdexamfetamine …"
]
}
},
"sources": [
{
"name": "NLM RxNorm (RxNav REST API)",
"url": "https://lhncbc.nlm.nih.gov/RxNav/APIs/RxNormAPIs.html"
}
]
},
"type": "json"
}